MyFinsight
Home
Blog
About
Other income
$3,629K
Stock-based compensation
expense
$31,226K
(-57.10%↓ Y/Y)
Proceeds from sales or
maturities of investments
$37,642K
(-78.32%↓ Y/Y)
Proceeds from issuance of
common stock from...
$2,193K
(-32.63%↓ Y/Y)
Deferred income tax
expense
$10,152K
Depreciation and
amortization
$4,597K
(-28.82%↓ Y/Y)
Accounts receivable
-$1,927K
(-104.35%↓ Y/Y)
Net (loss)
$314K
Other non-cash
expenses
$193K
(-81.32%↓ Y/Y)
Proceeds from the
exercise of stock options
$403K
(-95.32%↓ Y/Y)
Canceled cashflow
$3,315K
Revenue
$200,581K
Net cash provided by
(used in) operating...
$23,228K
(677.95%↑ Y/Y)
Net cash (used in)
provided by investing...
$3,548K
(-92.12%↓ Y/Y)
Net cash (used in)
financing activities
$1,911K
(102.27%↑ Y/Y)
Effect of exchange rate
on cash
$142K
(194.67%↑ Y/Y)
Canceled cashflow
$24,995K
Canceled cashflow
$34,094K
Canceled cashflow
$685K
Income tax expense
$2,801K
Operating income (loss)
-$514K
Canceled cashflow
$200,581K
Increase (decrease) in
cash and cash...
$28,829K
(166.70%↑ Y/Y)
Accounts payable
-$13,831K
(-217.05%↓ Y/Y)
Inventories
$4,217K
(-89.84%↓ Y/Y)
Accrued expenses and
other liabilities
-$3,905K
(65.47%↑ Y/Y)
Prepaid expenses and
other current assets
$2,805K
(338.97%↑ Y/Y)
Accretion of investment
discount
$237K
(-88.81%↓ Y/Y)
Purchases of investments
$24,934K
(-77.07%↓ Y/Y)
Capital expenditures
$9,160K
(-47.37%↓ Y/Y)
Payment of taxes on net
share settlement of...
$685K
(-96.73%↓ Y/Y)
Selling, general and
administrative expense...
$128,341K
Cost of goods sold
$29,122K
Research and development
expense
$24,698K
Advertising expense
$18,934K
Back
Back
Cash Flow
Inspire Medical Systems, Inc. (INSP)
Inspire Medical Systems, Inc. (INSP)
source: myfinsight.com